Academic literature on the topic 'Respiratory tract diseases/prevention e control'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Respiratory tract diseases/prevention e control.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Respiratory tract diseases/prevention e control"
Gurov, A. V., and M. A. Yushkina. "Adequate mucociliary clearance as a factor in the prevention and control of purulent-inflammatory pathology of the ENT organs." Meditsinskiy sovet = Medical Council, no. 6 (May 12, 2021): 29–34. http://dx.doi.org/10.21518/2079-701x-2021-6-29-34.
Full textChakraborty, Sandip, Amit Kumar, Ruchi Tiwari, Anu Rahal, Yash Malik, Kuldeep Dhama, Amar Pal, and Minakshi Prasad. "Advances in Diagnosis of Respiratory Diseases of Small Ruminants." Veterinary Medicine International 2014 (2014): 1–16. http://dx.doi.org/10.1155/2014/508304.
Full textBarr, Rachael, Christopher A. Green, Charles J. Sande, and Simon B. Drysdale. "Respiratory syncytial virus: diagnosis, prevention and management." Therapeutic Advances in Infectious Disease 6 (January 2019): 204993611986579. http://dx.doi.org/10.1177/2049936119865798.
Full textShulzhenko, A. E., I. N. Zuikova, A. V. Karaulov, and R. V. Shchubelko. "Effectiveness of the low-molecular inductor of interferon of Amiksin® in treatment and preventive maintenance of the chronic recurrent inflammatory diseases of the upper respiratory tract." Russian Journal of Biotherapy 15, no. 2 (June 30, 2016): 66–75. http://dx.doi.org/10.17650/1726-9784-2016-15-2-66-75.
Full textTarim, E. Alperay, Betul Karakuzu, Cemre Oksuz, Oyku Sarigil, Melike Kizilkaya, Mahmoud Khatib A. A. Al-Ruweidi, Huseyin Cagatay Yalcin, Engin Ozcivici, and H. Cumhur Tekin. "Microfluidic-based virus detection methods for respiratory diseases." Emergent Materials 4, no. 1 (February 2021): 143–68. http://dx.doi.org/10.1007/s42247-021-00169-7.
Full textSantana, Hericalizandra S. R., Fernanda O. de Carvalho, Erika R. Silva, Nayara G. L. Santos, Saravanan Shanmugam, Debora N. Santos, Julio O. Wisniewski, et al. "Anti-Inflammatory Activity of Limonene in the Prevention and Control of Injuries in the Respiratory System: A Systematic Review." Current Pharmaceutical Design 26, no. 18 (June 10, 2020): 2182–91. http://dx.doi.org/10.2174/1381612826666200320130443.
Full textYasmin, Farhana, and Md Jawadul Haque. "Acute Respiratory Infections (ARI) and Weaning Status of Infants Admitted in Selected Hospitals of Rajshahi- A Case Control Study." TAJ: Journal of Teachers Association 32, no. 1 (August 22, 2019): 70–81. http://dx.doi.org/10.3329/taj.v32i1.42740.
Full textZingg, Walter, Benedikt D. Huttner, Hugo Sax, and Didier Pittet. "Assessing the Burden of Healthcare-Associated Infections through Prevalence Studies: What Is the Best Method?" Infection Control & Hospital Epidemiology 35, no. 6 (June 1, 2014): 674–84. http://dx.doi.org/10.1086/676424.
Full textGuo, Zuiyuan, Kevin He, and Dan Xiao. "Early warning of some notifiable infectious diseases in China by the artificial neural network." Royal Society Open Science 7, no. 2 (February 2020): 191420. http://dx.doi.org/10.1098/rsos.191420.
Full textWolfe, Daniel N., Girish S. Kirimanjeswara, Elizabeth M. Goebel, and Eric T. Harvill. "Comparative Role of Immunoglobulin A in Protective Immunity against the Bordetellae." Infection and Immunity 75, no. 9 (June 25, 2007): 4416–22. http://dx.doi.org/10.1128/iai.00412-07.
Full textDissertations / Theses on the topic "Respiratory tract diseases/prevention e control"
Paraiso, Maria Leticia de Souza. "Avaliação do impacto à saúde causado pela queima prévia de palha de cana-de-açúcar no Estado de São Paulo." Universidade de São Paulo, 2013. http://www.teses.usp.br/teses/disponiveis/5/5137/tde-20022014-145043/.
Full textEthanol from sugarcane is consolidated as a renewable fuel which promotes further expansion of the culture of sugarcane in Brazil and especially in the State of São Paulo. As the controlled pre-harvest burning of sugarcane straw is still considered an agricultural practice necessary for the economic viability of this crop in more than 70% of municipalities in the State of São Paulo the population is forced to live with this pollution. To study the distribution of this risk factor and its relationship with the health of the population, I conducted an ecological study in the 645 municipalities of São Paulo. I used a Bayesian multivariate regression model relating the health effects and the exposure to previous straw burning of sugarcane, controlling the effects of socioeconomic factors (sanitation, education and income) and climate (maximum temperature, minimum humidity and precipitation) by the insertion of these variables in the model. The effect on health was measured by Standardized Mortality and Morbidity Ratio (SMR) of the outcomes: deaths from respiratory diseases in the age group above 65 years old and admissions for respiratory disease in children less than 5 years old and above 65 years old of each of the municipalities. I used as a measure of exposure to the pre-harvest burning data obtained at INPE: percent of sugarcane area harvest with burning (PMQ), levels of Aerosol and Spotlights of burning, tested separately. To solve the autocorrelation in the data these were considered as their spatial arrangement, by building a neighborhood matrix of the 645 municipalities in the state. I used the Markov Chain-Monte Carlo simulation method (MCMC) to \'soften\' the estimates of the SMR. The analysis showed that there is an association between previous straw burning of sugarcane and respiratory diseases, because the increase in outbreaks of burning (Spotlights) was significantly associated with increased hospital admissions for respiratory diseases in children aged under five years old. The results show that the previous straw burning of sugarcane effectively offers health risk to the population and added to the choropleth maps generated provide valuable information for epidemiological surveillance and contribute to the establishment of public policies for the control of air pollution, which should contemplate beyond the major urban centers, the small towns. The elimination of this risk factor should be part of a primordial prevention measure to be taken in the state
Soh, Kim Lam. "Knowledge about nosocomial pneumonia prevention among critical care nurses in New Zealand a thesis presented in partial fulfillment of the requirement for the degree of Master of Health Science, Auckland University of Technology, September 2003 /." Full thesis. Abstract, 2003. http://puka2.aut.ac.nz/ait/theses/SohK.pdf.
Full textAppendix B not included in e-thesis. Also held in print (128 leaves, 30 cm.) in Akoranga Theses Collection. (T 610.7361 SOH)
Vian, Bruna Scharlack 1979. "Efeito da aplicação nasal de diferentes soluçõeo salinas sobre os sintomas, sensibilidade olfativa e expressão de fator crescimento neural (NGF) em pacientes com rinopatia alégica persistente." [s.n.], 2012. http://repositorio.unicamp.br/jspui/handle/REPOSIP/311764.
Full textDissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas
Made available in DSpace on 2018-08-19T21:14:23Z (GMT). No. of bitstreams: 1 Vian_BrunaScharlack_M.pdf: 1879886 bytes, checksum: d9b52c103c4a6cca51810138e9c47e14 (MD5) Previous issue date: 2012
Resumo: A rinite alérgica (RA) é definida como uma inflamação da mucosa nasal, resultando em sintomas nasais que incluem rinorréia, obstrução, prurido e espirros. O fator de crescimento neural (NGF) está envolvido na fisiopatologia de inflamação alérgica. Soluções salinas nasais em diversas concentrações têm sido usadas para prevenir ou reduzir sintomas alérgicos, porém as concentrações ideais das soluções de cloreto de sódio nasal ainda não estão bem estabelecidas na literatura disponível. O objetivo desse estudo foi avaliar o efeito das soluções salinas: isotônica (ISO), hipertônica 3% (HIPER) e agua destilada (HIPO) em pacientes com RA persistente, comparando os escores clínicos dos sintomas nasais, avaliação do escore olfativo e a expressão gênica de NGF como marcador inflamatório do conteúdo celular nasal e considerando temperatura e umidade nos diferentes períodos em que utizaram as soluções. Trinta (30) pacientes com diagnóstico de RA persistente iniciaram o estudo, porem apenas 13 terminaram. Os pacientes foram divididos em 3 grupos aleatorizados que utilizaram as 3 soluções: ISO, HIPER e HIPO em 3 períodos diferentes (P1, P2 e P3). Os critérios clínicos de avaliação dos sintomas eram avaliados por meio de "Questionário Validado", onde somava-se o total do escore dos sintomas nasais (TESN). Para a avaliação do sintoma olfato era aplicado um escore olfativo de 0 a 8 com diluições de essência de eucalipto. Foi realizada coleta de material da mucosa nasal para o estudo da expressão gênica de NGF por meio de Reação de Polimerase em Cadeia (PCR). Os resultados observados neste estudo foram que no P1, os pacientes apresentaram melhora do TESN (p=0.004), quando comparada com a HIPER. Tanto o grupo que iniciou o tratamento com a solução ISO (p= 0,056), quanto o grupo que iniciou com HIPO (p= 0,063) tiveram uma tendência de melhora quando comparada com a HIPER. Todos os grupos no P1 apresentaram melhora do escore olfativo. O grupo que iniciou com a solução HIPER mostrou valores de expressão de NGF significativamente maiores (p=0,023). Conclui-se então, que as soluções salinas podem ser utilizadas como tratamento adjuvante na RA, pois melhorou os sintomas e melhorou o escore olfativo, porém a solução HIPER aumentou expressão de NGF na mucosa nasal
Abstract: Allergic rhinitis (AR) is defined as inflammation of the nasal mucosa, resulting in nasal symptoms including rhinorrhea, obstruction, itching and sneezing. Neural growth factor (NGF) is involved in the pathophysiology of allergic inflammation. Nasal saline solutions, at various concentrations, have been used to prevent or reduce allergic symptoms, but the ideal concentration of nasal sodium chloride solutions are not well established in the literature. The objective were to evaluate the effect of salt solutions such as isotonic (ISO), hypertonic (3% NaCl - HYPER) and hypotonic (sterile distilled water - HYPO) in patients with persistent allergic rhinitis, comparing clinical scores of nasal symptoms and olfactory score, as well as NGF expression as an inflammatory marker of nasal cell content. Thirteen (13) patients of thirty (30) with diagnosed persistent AR were divided into three randomized groups that used three solutions: ISO, HYPO and HYPER, during three periods (P1, P2 and P3). Clinical evaluation criteria of symptoms were determined by a validated questionnaire that evaluated the total nasal symptom score (TNSS). Nasal mucosa material was collected to analyze NGF expression assessed by the Polymerase Chain Reaction (PCR). The results were: patients showed an improvement in TNSS (p = 0.004) during the first period. The group that began treatment using the ISO solution (p = 0.056), as well the group that started using the HYPO (p = 0.063) showed a trend of improvement in TNSS, when compared with the HYPER group. All groups showed improvement in olfactory score during de first period. With regard to NGF gene expression, the group treated with the HYPER solution showed significantly higher levels (p=0.023) of expression compared with patients treated with the other nasal solutions. The conclusion was that the salt solutions may be used as adjuvant therapy in AR, due to the fact that they improve symptoms and olfactory score. Hyper saline solution can increase the expression of NGF in nasal mucosa
Mestrado
Clinica Medica
Mestre em Clinica Medica
Veeranki, Sreenivas P., Shimin Zheng, Yan Cao, and Arsham Alamian. "Association of Serum Vitamin D Levels with Respiratory and Atopic Diseases." Digital Commons @ East Tennessee State University, 2014. https://dc.etsu.edu/etsu-works/91.
Full textMonteiro, Ana Isabel Melo Pereira [UNIFESP]. "Profilaxia da infecção por vírus sincicial respiratório: estudo clínico prospectivo de crianças submetidas ao uso de palivizumabe." Universidade Federal de São Paulo (UNIFESP), 2012. http://repositorio.unifesp.br/handle/11600/9981.
Full textO Vírus Sincicial Respiratório (VSR) é o principal agente em infecções agudas do trato respiratório inferior (IATRI) antes de dois anos, com altas taxas de internação e óbito em crianças de alto risco para infecção grave pelo VSR. Objetivo: Identificar os vírus envolvidos nos quadros de infecções agudas de trato respiratório (IATR) e analisar taxas de internação e óbito em crianças submetidas à profilaxia com palivizumabe. Métodos: Coorte prospectiva com 198 crianças menores de um ano de idade nascidas antes de 29 semanas de idade gestacional e crianças menores de 2 anos de idade com cardiopatia hemodinamicamente instável ou doença pulmonar crônica que receberam palivizumabe para profilaxia contra infecções graves pelo VSR em 2008. Nesse período, em cada episódio de IATR foi coletado aspirado de nasofaringe (NPA) para identificação de VSR, adenovírus, parainfluenza 1, 2 e 3, influenza A e B por imunofluorescência direta, e rinovírus e metapneumovírus por RT-PCR. Foram monitoradas internações e óbitos nesse grupo. Resultados: Das 198 crianças acompanhadas, 117 (59,1%) apresentaram IATR, totalizando 175 episódios. Das 76 NAPs coletadas, 37 foram positivas, encontrando-se, rinovírus em 75,7% dessas amostras, VSR (18,9%), parainfluenza (28,1%), adenovírus (2,7%), metapneumovírus (2,7%) e co-infecção em três amostras. Das 48 internações, 18 ocorreram por causa respiratória, sendo apenas 1 por VSR. Em nenhuma das duas crianças que evoluíram para óbito detectou-se o VSR. Conclusão: Na vigência de profilaxia com palivizumabe, a frequência de isolamento de VSR em crianças de alto risco com IATR e naquelas que necessitaram de internação hospitalar foi baixa.
Respiratory Syncytial Virus (RSV) is the most important etiologic agent in acute lower respiratory tract infections (ALRTIs) in children under two years, with high rates of hospitalization and death in high risk children for severe RSV infection. Objective: To identify the virus present in acute respiratory tract infections (ARTIs) and to analyze rates of hospitalization and death in children who received palivizumab prophylaxis. Methods: Prospective cohort of 198 infants up to 1 year old born before 29 weeks gestation and infants less than two years of age with hemodynamically instable cardiopathy or chronic pulmonary disease, who received prophylactic palivizumab against severe RSV infections in 2008. During this period, a nasopharyngeal aspirate (NPA) was collected in each episode of ARTI for identification of RSV, adenovirus, parainfluenza 1, 2 and 3, influenza A and B by direct immunofluorescence, and rhinovirus and metapneumovirus for RT-PCR. Data regarding hospitalization and death were collected. Results: Of the 198 infants included, 117 (59,1%) presented ARTIs, with a total of 175 episodes. Of 76 NPAs collected, 35 were positive, being rhinovirus (75.7%), RSV (18.9%), parainfluenza (8.1%), adenovirus 2 (2.7%), metapneumovirus (2.7%) and 3 samples presented multiple agents. Of 48 hospitalizations, 18 presented respiratory causes, but in only one child was found RSV. None of the 2 children who died had RSV. Conclusion: During the palivizumab prophylaxis period, the frequency of RSV detected in high risk children with ARTIs and those who were hospitalized was low.
TEDE
BV UNIFESP: Teses e dissertações
Tornimbene, Barbara. "Epidemiological investigation of highly pathogenic porcine reproductive and respiratory syndrome (HP-PRRS) in small and medium scale swine farms in the Cambodian Meking lowland region." Thesis, Royal Veterinary College (University of London), 2013. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.618314.
Full textMartins, Pedro Miguel Carvalho Diogo Carreiro. "Mecanismos de inflamação brônquica resultantes da exposição a factores ambientais." Doctoral thesis, Faculdade de Ciências Médicas. Universidade Nova de Lisboa, 2012. http://hdl.handle.net/10362/8339.
Full textBenkouiten, Samir. "Les infections respiratoires aigües chez les pélerins du Hajj." Thesis, Aix-Marseille, 2014. http://www.theses.fr/2014AIXM5042.
Full textAnnually, over two million Muslims from more than 180 countries gather in the Kingdom of Saudi Arabia to perform the pilgrimage to Mecca, also known as the "Hajj". Respiratory viruses, and especially influenza virus, are the most common cause of acute respiratory infection among pilgrims.We conducted a review to summarize the evidence related to the effectiveness of non-pharmaceutical interventions in preventing the spread of respiratory infectious diseases during the Hajj. Overall, although hand hygiene compliance is high among pilgrims, face mask use and social distancing remain difficult challenges. Data about the effectiveness of these measures at the Hajj are limited, and results are contradictory, highlighting the need for future large-scale studies.In 2012 and 2013, we conducted for the first time a prospective longitudinal study of pilgrims, to determine the prevalence of viruses and bacteria potentially responsible for acute respiratory symptoms, before departing from France for the Hajj and before leaving Saudi Arabia. We thus demonstrated the acquisition of respiratory viruses, most notably rhinovirus, coronaviruses (other than MERS-CoV), and influenza viruses, by pilgrims during their stay in Saudi Arabia. None of the pilgrims was positive for MERS-CoV. Also, while vaccination coverage against pneumococcal infection is low among pilgrims, many of them have acquired Streptococcus pneumoniae
Books on the topic "Respiratory tract diseases/prevention e control"
McLaughlin, Arthur J. Infection control in respiratory care. 2nd ed. Austin, Tex: Pro-Ed, 2004.
Find full textRoberto, Palermo, and McLaughlin Arthur J. 1947-, eds. Infection control in respiratory care. 2nd ed. Gaithersburg, Md: Aspen Publishers, 1996.
Find full textKeizo, Chiyotani, and Hosoda Yutaka, eds. Advances in the prevention of occupational respiratory diseases: Proceedings of the 9th International Conference on Occupational Respiratory Diseases, Kyoto, 13-16 October 1997. New York: Elsevier, 1998.
Find full textFlannigan, B. Microorganisms in home and indoor work environments: Diversity, health impacts, investigation and control. 2nd ed. Boca Raton, FL: CRC Press, 2011.
Find full textMicroorganisms in home and indoor work environments: Diversity, health impacts, investigation, and control. 2nd ed. Boca Raton: Taylor & Francis, 2011.
Find full textRegional, Workshop on Acute Respiratory Infections (1986 Manila Philippines). Regional Workshop on Acute Respiratory Infections. Manila, Philippines: Printed and distributed by the Regional Office for the Western Pacific, 1987.
Find full textBollinger, Nancy J. NIOSH guide to industrial respiratory protection. Cincinnati, Ohio: U.S. Dept. of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, Division of Safety Research, 1987.
Find full textBollinger, Nancy J. NIOSH guide to industrial respiratory protection. Cincinnati, Ohio: U.S. Dept. of Health and Human Services, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, Division of Safety Research, 1987.
Find full textHealth, Institute of Medicine (U S. ). Committee on Damp Indoor Spaces and. Damp indoor spaces and health. Washington, DC: National Academies Press, 2004.
Find full textMeyers, Casey. Aerobic walking: The best and safest, weight loss and cardiovascular exercise for everyone overweight or out of shape. New York: Vintage Books, 1987.
Find full textBook chapters on the topic "Respiratory tract diseases/prevention e control"
Andersen, Bjørg Marit. "Suction of Respiratory Tract Secretions." In Prevention and Control of Infections in Hospitals, 323–32. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-99921-0_28.
Full textAndersen, Bjørg Marit. "Protection of Upper Respiratory Tract, Mouth and Eyes." In Prevention and Control of Infections in Hospitals, 129–46. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-99921-0_13.
Full textWang, Yali, and Qun Li. "Risk and Prevention of Middle East Respiratory Syndrome (MERS)." In Prevention and Control of Infectious Diseases in BRI Countries, 133–41. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-33-6958-0_11.
Full textPeter Burney, Perez-Padilla, Rogelio, Guy Marks, Gary Wong, Eric Bateman, and Deborah Jarvis. "Chronic Lower Respiratory Tract Diseases." In Disease Control Priorities, Third Edition (Volume 5): Cardiovascular, Respiratory, and Related Disorders, 263–85. The World Bank, 2017. http://dx.doi.org/10.1596/978-1-4648-0518-9_ch15.
Full textAnderson, Henry A., Carrie Tomasallo, and Mark A. Werner. "17. Chronic Respiratory Diseases." In CHRONIC DISEASE EPIDEMIOLOGY, PREVENTION, AND CONTROL, 4th edition. American Public Health Association, 2016. http://dx.doi.org/10.2105/9780875532783ch17.
Full textIftikhar, Salma, Mary Jo Kasten, and Zelalem Temesgen. "Infectious Diseases." In Mayo Clinic Preventive Medicine and Public Health Board Review, 73–90. Oxford University Press, 2010. http://dx.doi.org/10.1093/med/9780199743018.003.0006.
Full textHuskins, W. Charles. "Health Care–Associated Infection Prevention and Control Programs." In Mayo Clinic Infectious Diseases Board Review, 31–40. Oxford University Press, 2012. http://dx.doi.org/10.1093/med/9780199827626.003.0003.
Full textThompson, Warren G., and Darryl S. Chutka. "Secondary Prevention 2: Common Clinical and Chronic Diseases." In Mayo Clinic Preventive Medicine and Public Health Board Review, 159–78. Oxford University Press, 2010. http://dx.doi.org/10.1093/med/9780199743018.003.0011.
Full textDamani, Nizam. "Special pathogens." In Manual of Infection Prevention and Control, 338–427. Oxford University Press, 2019. http://dx.doi.org/10.1093/med/9780198815938.003.0009.
Full textBenmaamar, Ramla, Madeleine Smith, and Derek Yach. "Noncommunicable Diseases." In Social Injustice and Public Health, 287–306. Oxford University Press, 2019. http://dx.doi.org/10.1093/oso/9780190914653.003.0015.
Full text